Helping Children Receive an Earlier Autism Diagnosis

Earlier Diagnosis + Earlier Intervention = Better Outcomes

A NEW DIAGNOSTIC TOOL

Our NPDX ASD test may lead to an earlier diagnosis for children with autism spectrum disorder (ASD).

Earlier access to specialty care and treatments improve outcomes

Posters & Publications

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Amino Acid Dysregulation Metabotypes – Biological Psychiatry article

Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder Smith AM, King JJ, West PR, Ludwig MA, Donley ELR, Burrier RE, Amaral DG. Abstract BACKGROUND: Autism spectrum disorder (ASD) is behaviorally and biologically heterogeneous and likely represents a series of conditions arising from different underlying genetic, metabolic,[…]

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Identification of Neurotransmitter-Associated and Other Metabotypes: Further Stratification of the Children’s Autism Metabolome Project (CAMP) ASD Subjects

Presented at the 2019 Annual Meeting of the International Society for Autism Research (INSAR) in Montreal, Ontario, Canada in May 2019. The Children’s Autism Metabolome Project (CAMP), ClinicalTrials.gov: NCT02548442, recruited 1,100 children for metabolomic analyses to identify altered metabolism associated with ASD. Previous research identified ASD subjects associated with branched-chain amino acid (BCAA) dysregulation. With this[…]

NEWS

Metabolism Based Diagnosis and Precision Medicine for Autism Spectrum Disorders

Video of presentation at The National TACA Autism Conference – East Coast in Atlanta, Georgia, March 2019. In this video, Beth Donley shares her history as an autism mom as well as details about the NeuroPointDX NPDX ASD test, which is a blood test that can identify about 30% of children with autism spectrum disorder[…]